Status: Not yet recruiting
Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting
PEGASO is an observational study designed to collect prospective data on the effectiveness and safety of pegunigalsidase alfa in adult patients with Fabry disease, being treated or planning to start treatment, under real-world setting.
Participants needed: 75
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chiesi ItaliaUpdated: Feb 24, 2026Locations: 1
Eligibility criteria
Male and female adults (≥ 18 years). [+3]
History of hypersensitivity reaction to pegunigalsidase alfa. [+2]